Keywords: positive, results, ista, bepreve, firm, pharmaceuticals, announced

More positive results for ISTA's Bepreve

Article | 12 May 2008

Print This

US firm ISTA Pharmaceuticals has announced positive preliminary results from the second Phase III trial on its candidate Bepreve (bepotastine ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in